Skip to main content
Sign In

University of Colorado Cancer Center

University of Colorado Cancer Center, A National Cancer Institute-designated Comprehensive Cancer Center
 

Paul A. Bunn, Jr, MD and Barb Helfrich, MSc

Preceptors


Categories:

Cell growth, death and senescence, signaling pathways and experimental and molecular therapeutics

Specialty:

Lung Cancer, Medical Oncology

Location:

University of Colorado Anschutz Medical Campus

Prerequisites:

Must have completed two years of college

Openings: 1

Program Overview:

To learn experimental techniques used in basic cancer research, especially those employing new treatment modalities to interrupt the growth factor pathways of lung cancer.

Program Description:

Students will be involved with a variety of laboratory procedures, including: 1) cell culture of human lung cancer cell lines;  2) assays to assess treatment cytotoxicity: growth curves, clonogenic assays, and MTT assay;  3) treatment of cell lines with novel molecularly targeted agents or shRNA alone and in combination that target growth factor pathways critical to tumor cell survival; and  4) studies to determine the mechanism of action of candidate agents with potential therapeutic utility in lung cancers (Western blots).